Sanofi to produce 100 million Pfizer/BioNTech vaccine doses, CEO says
Reuters | Paris | Updated: 26-01-2021 23:03 IST | Created: 26-01-2021 22:54 IST
French pharma giant Sanofi will produce more than 100 million doses of the COVID-19 vaccine developed by its competitors Pfizer and BioNTech by the end of the year, CEO Paul Hudson told Le Figaro newspaper in an interview published on Tuesday.
As Sanofi and its British partner GlaxoSmithKline have delayed the launch of their shot to late 2021, the French company decided to approach Pfizer "in order to be helpful as of now", Hudson said, adding that an agreement with the U.S. company had been reached.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
ALSO READ
Brazil government ministers have virtual meeting with U.S. climate envoy Kerry
Athletics-Giles runs second-fastest indoor 800m, sets new British mark
FOREX-Dollar buoyed by strong U.S. data, Bitcoin near record $52,640
Automakers, medical device firms ask Biden for U.S. chip factory subsidies
How the battle over redistricting in 2021 could decide control of the U.S. Congress